<DOC>
	<DOC>NCT01278004</DOC>
	<brief_summary>This study is a drug trial of ethosuximide as a painkiller if you develop pain as a side effect of chemotherapy. Ethosuximide will be compared against placebo (an inactive substance) to test whether any response is a true effect of the drug, and not a 'placebo effect'.</brief_summary>
	<brief_title>Chemotherapy Induced Painful Peripheral Neuropathy Ethosuximide (The CIN-E Study)</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Ethosuximide</mesh_term>
	<criteria>Age &gt;/= 18 Diagnosis of cancer Willing and able to give informed consent to the CINE study and complete study questionnaires, this involves adequate understanding of written and spoken English (translators will not be used) Chemotherapyinduced painful peripheral neuropathy as diagnosed by score of &gt;12 on the Leeds Assessment of Neuropathic Symptoms and Signs (SLANSS) with a pain intensity rating of &gt;4, on a 11 point numeric rating scale (0= no pain, 10= worst possible pain). Duration of chemotherapyinduced painful peripheral neuropathy &gt;4 weeks. Participant may either have completed chemotherapy, or be receiving ongoing chemotherapy. Able to attend research centre according to the required visit schedule. Diet allows bovine gelatine (present in both ethosuximide and placebo capsules) Women of childbearing potential must be using a reliable form of contraception i.e. oral contraceptives, a barrier method (condom or diaphragm), intrauterine device or abstinence. Renal impairment (serum creatinine &gt;1.5x normal level) Deranged liver function (AST&gt;3x normal level) Patients currently taking any antidepressant medication, for example fluoxetine, paroxetine, citalopram, venlafaxine, amitriptyline, or within the past week. Patients currently taking any other antiepileptic drug, including gabapentin, or within the past week. Pregnancy Allergy to succinimides, ethosuximide, methsuximide, phensuximide. Preexisitng painful peripheral neuropathy of any other cause.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Adult cancer patients with chemotherapy-induced painful peripheral neuropathy</keyword>
</DOC>